Souhaitez-vous accéder aux communiqués récents ?

The inaugural Blood Cancer Heroes® event in Orlando, FL, will honor those who have made tremendous contributions to the blood cancer community.

NORWALK, Conn., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Multiple Myeloma Research Foundation® (MMRF®) today announced that its 9th annual Road to Victories ride will take place in California’s Death...

First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma450 million cell dose is the recommended...

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Multiple Myeloma Market Size, Insights, Analysis, Growth Potential and Forecasts 2025-2033" report has been added to ...

TOLREMO therapeutics Welcomes Multiple Myeloma Leader Kenneth C. Anderson to its Scientific Advisory Board

NAGOYA, Japan, Oct. 16, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) will be holding the Asian Myeloma Network (AMN) awards ceremony on Saturday, October 18, during the 9th...

EXTON, PA, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Spherix Global Insights, a leading independent market intelligence and advisory firm that delivers commercial value to the global life sciences industry,...

LOS ANGELES, Oct. 14, 2025 (GLOBE NEWSWIRE) -- It is with great sadness that the International Myeloma Foundation (IMF) shares the news of the death of Dr. Brian G.M. Durie, co-founder of the...

New York, USA, Oct. 08, 2025 (GLOBE NEWSWIRE) -- CAR T-Cell Therapy for Multiple Myeloma Market to Witness Upsurge in Growth by 2034 Owing to the Launch of Emerging Therapies | DelveInsight The...

STUDIO CITY, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) announced today that Heather Cooper Ortner — President & CEO of Alzheimer’s Los Angeles, and...